본문 바로가기

Influenza mimetic protein-polymer nanoparticles as antigen delivery vehicles to dendritic cells for cancer immunotherapy

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q1Scopus Q1
저널
NANOSCALE11(29) · pp.13878 · 2019
피인용
Web of Science 9Scopus 10
FWCI (Scopus)
0.5
JCR IF
JCR 2018 6.97
ISSN
2040-3364

저자

  1. 이채연제1저자Department of Polymer Science and Engineering, Pusan National University Busan Republic of Korea 46241 Email: hpaik@pusan.ac.kr
  2. 리자Department of Polymer Science and Engineering, Pusan National University Busan Republic of Korea 46241 Email: hpaik@pusan.ac.kr
  3. Shim, KyuHwanDepartment of Bionano Technology, Gachon University Sungnam Republic of Korea 13120
  4. An, Seong Soo A.Department of Bionano Technology, Gachon University Sungnam Republic of Korea 13120
  5. Jang, SunahResearch Center for Bio-Based Chemistry, Korea Research Institute of Chemical Technology (KRICT) Daejeon Korea 34114
  6. Song, Jae KwangResearch Center for Bio-Based Chemistry, Korea Research Institute of Chemical Technology (KRICT) Daejeon Korea 34114
  7. Jin, Jun-O교신저자Shanghai Public Health Clinical Center, Shanghai Medical College, Fudan University Shanghai 201508 Email: hpaik@pusan.ac.kr
  8. 백현종Department of Polymer Science and Engineering, Pusan National University Busan Republic of Korea 46241 Email: hpaik@pusan.ac.kr

초록

© The Royal Society of Chemistry 2019.Stimulation of dendritic cells (DCs) by antigens (Ags) promotes an Ag-specific immune response that kills Ag-expressing pathogens. These biologically inspired nanocarriers have received much attention as tools to deliver cancer Ags to DCs. A polymer-templated protein nanoball having hemagglutinin (H1-NB) that mimics the influenza virus can be used as a cancer Ag delivery vehicle, as DCs show effective phagocytic activities against H1-NB without any adjuvant. In the present study, H1-NB containing ovalbumin (OVA), a model Ag (H1-OVA-NB), was prepared as an anti-cancer agent and evaluated for its effect on anticancer immunity. H1-OVA-NB treatments in C57BL/6 mice enhanced OVA-specific immune activation and efficiently inhibited B16-OVA tumor growth compared to control groups. Our results indicate that H1-NB is an effective carrier for Ag delivery to DCs and promotes immunotherapy to fight cancer.

식별자

Scopus EID
2-s2.0-85069678410
WoS UID
000477704400018